Literature DB >> 30121018

Worsening renal function during decongestion among patients hospitalized for heart failure: Findings from the Evaluation Study of Congestive Heart Failure and Pulmonary Artery Catheterization Effectiveness (ESCAPE) trial.

Marat Fudim1, Rahul Loungani2, Shannon M Doerfler3, Adrian Coles3, Stephen J Greene4, Lauren B Cooper5, Mona Fiuzat3, Christopher M O'Connor5, Joseph G Rogers2, Robert J Mentz4.   

Abstract

INTRODUCTION: Worsening renal function (WRF) can occur throughout a hospitalization for acute heart failure (HF). However, decongestion can be measured in different ways and the prognostic implications of WRF in the setting of different measures of decongestion are unclear.
METHODS: Patients (N = 433) from the ESCAPE were classified by measures of decongestion during hospitalization: hemodynamic (right atrial pressure ≤8 mmHg and/or wedge pressure ≤15 mmHg at discharge), clinical (≤1 sign of congestion at discharge), hemoconcentration (any increase in hemoglobin) and estimated plasma volume using the Hakim formula (5% reduction in plasma volume). WRF was defined as creatinine increase ≥0.3 mg/dl during hospitalization. The association between WRF and 180-day all-cause death was assessed.
RESULTS: Successful decongestion was observed in 124 (60%) patients by hemodynamics, 204 (49%) by clinical exam, 173 (47%) by hemoconcentration, and 165 (45%) by plasma volume. There was no agreement between the hemodynamic assessment and other decongestion measures in up to 43% of cases. Persistent congestion with concomitant WRF at discharge was associated with worse outcomes compared to patients without congestion and WRF. Among patients decongested at discharge, in-hospital WRF was not significantly associated with 180-day all-cause death, when using hemodynamic, clinical or estimated plasma volume as measures of decongestion (P > .05 for all markers).
CONCLUSIONS: In patients hospitalized for HF, although there was disagreement across common measures of decongestion, in-hospital WRF was not associated with increased hazard of all-cause mortality among patients successfully decongested at discharge.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30121018     DOI: 10.1016/j.ahj.2018.07.019

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  14 in total

1.  Mechanistic Insights into Loop Diuretic Responsiveness in Heart Failure.

Authors:  David H Ellison
Journal:  Clin J Am Soc Nephrol       Date:  2019-04-22       Impact factor: 8.237

Review 2.  The role of the kidney in acute and chronic heart failure.

Authors:  Gaetano Ruocco; Alberto Palazzuoli; Jozine M Ter Maaten
Journal:  Heart Fail Rev       Date:  2020-01       Impact factor: 4.214

3.  When Increase in Serum Creatinine Doesn't Imply Kidney Damage.

Authors:  Linda Fried
Journal:  Clin J Am Soc Nephrol       Date:  2020-02-28       Impact factor: 8.237

Review 4.  Medical Management of Heart Failure With Reduced Ejection Fraction in Patients With Advanced Renal Disease.

Authors:  Aaron M Hein; Julia J Scialla; Daniel Edmonston; Lauren B Cooper; Adam D DeVore; Robert J Mentz
Journal:  JACC Heart Fail       Date:  2019-05       Impact factor: 12.035

5.  Worsening Renal Function during Acute Decompensated Heart Failure: A Bad Signal Never to Ignore.

Authors:  Sang-Hyeon Park; Jeehoon Kang
Journal:  Int J Heart Fail       Date:  2021-04-14

6.  Systematic Review of the Association Between Worsening Renal Function and Mortality in Patients With Acute Decompensated Heart Failure.

Authors:  Takayuki Yamada; Hiroki Ueyama; Nitin Chopra; Takahiro Yamaji; Kengo Azushima; Ryu Kobayashi; Sho Kinguchi; Shingo Urate; Toru Suzuki; Eriko Abe; Yusuke Saigusa; Hiromichi Wakui; Paulina Partridge; Alfred Burger; Claudio A Bravo; Maria A Rodriguez; Juan Ivey-Miranda; Kouichi Tamura; Jeffery Testani; Steven Coca
Journal:  Kidney Int Rep       Date:  2020-07-02

7.  Heart failure and acute renal dysfunction in the cardiorenal syndrome.

Authors:  Rajinder S Chahal; Chukwuma A Chukwu; Paul R Kalra; Philip A Kalra
Journal:  Clin Med (Lond)       Date:  2020-03       Impact factor: 2.659

Review 8.  Pharmacologic and interventional paradigms of diuretic resistance in congestive heart failure: a narrative review.

Authors:  Simge Acar; Sueda Sanli; Cinar Oztosun; Baris Afsar; Alan A Sag; Masanari Kuwabara; Adrian Covic; Alberto Ortiz; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2021-01-03       Impact factor: 2.370

9.  Implications of renin-angiotensin-system blocker discontinuation in acute decompensated heart failure with systolic dysfunction.

Authors:  Douglas Darden; Mark H Drazner; Wilfried Mullens; Matthias Dupont; W H Wilson Tang; Justin L Grodin
Journal:  Clin Cardiol       Date:  2019-09-09       Impact factor: 2.882

10.  The impact of worsening renal function with elevated B-type natriuretic peptide at discharge on 1-year prognosis in heart failure patients.

Authors:  Toshitaka Okabe; Takehiko Kido; Taro Kimura; Tadayuki Yakushiji; Yu Asukai; Suguru Shimazu; Jumpei Saito; Yuji Oyama; Wataru Igawa; Morio Ono; Seitaro Ebara; Kennosuke Yamashita; Myong Hwa Yamamoto; Kisaki Amemiya; Naoei Isomura; Masahiko Ochiai
Journal:  Sci Rep       Date:  2020-03-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.